Aberrant aggregation of the misfolded presynaptic protein, α-Synuclein (α-Syn) into Lewy
body (LB) and Lewy neuritis (LN) is a major pathological hallmark of Parkinson's disease …

The aggregation of α‐synuclein (α‐Syn) is a key pathological hallmark of Parkinson's
disease (PD). α‐Syn undergoes liquid‐liquid phase separation (LLPS) to drive amyloid …

Liquid–liquid phase separation (LLPS) is a crucial phenomenon for the formation of
functional membraneless organelles. However, LLPS is also responsible for protein …

Abstract α-Synuclein (α-Syn) aggregation and amyloid formation is directly linked with
Parkinson's disease pathogenesis. However, the early events involved in this process …

Abstract α-Synuclein (α-Syn) is an aggregation-prone protein whose accumulation in Lewy
bodies leads to neurodegenerative diseases like Parkinson's disease (PD). Calcium plays a …

Parkinson's disease (PD) is a severe neurological disorder that affects more than 1 million
people in the US alone. A hallmark of PD is the formation of intracellular α-synuclein (α-Syn) …

Background Aggregation of the α-Synuclein (α-Syn) protein, amyloid fibril formation and
progressive neurodegeneration are the neuropathological hallmarks of Parkinson's Disease …

The aggregation of α‐synuclein (α‐Syn) is a critical pathological hallmark of Parkinson's
disease (PD). Prevention of α‐Syn aggregation has become a key strategy for treating PD …

Parkinson's disease (PD) is a neurological disorder marked by the presence of cytoplasmic
inclusions, Lewy bodies (LBs) and Lewy neurites (LNs) as well as the degeneration of …

Misfolded α-synuclein is a major component of Lewy bodies, which are a hallmark of
Parkinson's disease (PD). A large body of evidence shows that α-synuclein can aggregate …